✦ LIBER ✦

ROUTINE EARLY EPTIFIBATIDE, INFARCT SIZE, AND OUTCOMES IN NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME PATIENTS WITH ELEVATED TROPONIN ON ADMISSION

✍ Scribed by Saman Rasoul; Arnoud van't Hof; Robert Clare; Dan Atar; Stefan James; Jean-Francois Tanguay; Amadeo Betriu; gerard brogan; Robert Giugliano; L. Kristin Newby

Book ID: 118582309
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 90 KB
Volume: 59
Category: Article
ISSN: 1558-3597
DOI: 10.1016/s0735-1097(12)60499-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Tirofiban and eptifibatide treatment of

Tirofiban and eptifibatide treatment of patients presenting with acute coronary syndrome with non-ST segment elevation

✍ Corominas, Nuria ;Perez, Joaquin ;Ortiz, Jose ;Ferrer, Elena ;Ribas, Josep ;Sanz 📂 Article 📅 2004 🏛 Springer 🌐 Dutch ⚖ 156 KB

The effect of routine, early invasive ma

The effect of routine, early invasive management on outcome for elderly patients with non-ST-segment elevation acute coronary syndromes

✍ R.G. Bach; C.P. Cannon; W.S. Weintraub 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Combined Prognostic Utility of ST Segmen

Combined Prognostic Utility of ST Segment in Lead aVR and Troponin T on Admission in Non–ST-Segment Elevation Acute Coronary Syndromes

✍ Masami Kosuge; Kazuo Kimura; Toshiyuki Ishikawa; Toshiaki Ebina; Kiyoshi Hibi; K 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 168 KB

GREATER ST-SEGMENT ELEVATION IN LEAD AVR

GREATER ST-SEGMENT ELEVATION IN LEAD AVR IS ASSOCIATED WITH WORSE OUTCOMES IN PATIENTS WITH NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME

✍ Masami Kosuge; Toshiaki Ebina; Kiyoshi Hibi; Satoshi Morita; Mitsuaki Endo; Nobu 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 243 KB

Prognostic Value of Troponins in Patient

Prognostic Value of Troponins in Patients with Non-ST-segment Elevation Acute Coronary Syndromes and Chronic Kidney Disease

✍ Chiara Melloni; Karen P. Alexander; Sarah Milford-Beland; L. Kristin Newby; Lynd 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 188 KB

Eptifibatide does not suppress the incre

Eptifibatide does not suppress the increase of inflammatory markers in patients with non-ST-segment elevation acute coronary syndrome

✍ Alexey A. Mazaev; Yaroslav A. Naimushin; Valery P. Masenko; Mikhail Y. Ruda; Ale 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 205 KB